Skip to content
Stop using now Drug recall · FDA · Published May 21, 2013

Baxter Recalls Sodium Chloride Injection Due to Sterility Risk

Baxter Healthcare Corp. recalls specific lots of Sodium Chloride Injection, USP in Viaflex containers due to potential administration port leakage and lack of sterility assurance.

🇺🇸 FDA recall #D-628-2013DrugBaxter ›
Take action

Contact the company

Recalling firmBaxter Healthcare Corp.1 Baxter Pkwy · Deerfield, IL 60015-4625
✎ GovInfoNow plain-language explainer

Baxter Healthcare Corp. is recalling specific lots of Sodium Chloride Injection, USP packaged in Viaflex containers because of a manufacturing issue that may cause the administration port to leak. This defect compromises the assurance of sterility, meaning the medication could be contaminated if used. The recall covers approximately 1.7 million units distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/47885-baxter-healthcare-corp-recalls-sodium-chloride-injection-usp-a-product.

Source Summary by GovInfoNow · govinfonow.com/recall/47885-baxter-healthcare-corp-recalls-sodium-chloride-injection-usp-a-product · Updated October 13, 2026 · FDA enforcement record: FDA #D-628-2013

Cite this page

“Baxter Recalls Sodium Chloride Injection Due to Sterility Risk.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/47885-baxter-healthcare-corp-recalls-sodium-chloride-injection-usp-a-product. Based on FDA recall #D-628-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-628-2013%22&limit=1).

The FDA announced on May 21, 2013, that Baxter Healthcare Corp. recalled Sodium Chloride Injection, USP, due to a lack of sterility assurance caused by potential administration port leakage. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Baxter
  • Product: Sodium Chloride Injection Viaflex
  • Product code 2B1301- 50 mL in Viaflex Container Quad Pack (NDC 0338-0049-11)
  • Product code 2B1302- 100mL in Viaflex Quad Pack (NDC 0338-0049-18)
  • Product code 2B1306- 50 mL in Viaflex Single Pack (NDC 0338-0049-41)
  • Product code 2B1307- 100mL in Viaflex Single Pack (NDC 0338-0049-48)
  • Product code 2B1308- 50 ML in Viaflex Multi Pack (NDC 0338-0049-31)
  • Product code 2B1309- 100mL in Viaflex Multi Pack (NDC 0338-0049-38)
  • Lot codes: P279943, P280370, P280248, P280248A, P280248B, P285346, P285791, P285601, P280347, P280404, P280404A, P285635, P285858, P280149
  • Distribution: Nationwide & Puerto Rico

The hazard

According to the FDA, specific lot numbers of these products have been identified for potential administration port leakage resulting from a manufacturing issue during the sealing of the closure assembly. This defect creates a lack of assurance of sterility for the Sodium Chloride Injection, USP.

Context

GovInfoNow's records show Baxter Healthcare Corp. has 34 other recalls on record since September 21, 2012. Other recent recalls of similar products include Baxter Amia Dialysis Set Recall (September 1, 2017), Baxter Recalls Brevibloc Injection Due to Discoloration (April 12, 2016), and Baxter Recalls Sodium Chloride Irrigation Due to Insect Contamination (February 5, 2016). Additional recent recalls include Baxter Vasopressin Injection Recall (August 6, 2026), Baxter 0.9% Sodium Chloride Injection Recall (August 17, 2026), and Huons Co. 10mL Sodium Chloride Injection Recall (April 2, 2026).

How to tell if you have this one

Check your inventory for Sodium Chloride Injection, USP in Viaflex Containers (Quad Pack, Single Pack, or Multi Pack) with Product codes 2B1301, 2B1302, 2B1306, 2B1307, 2B1308, or 2B1309. Verify the Lot numbers and Expiration dates against the record: P279943/P280370 (Exp 7/13); P280248, P280248A, P280248B, P285346, P285791 (Exp 8/13); P285601 (Exp 5/13); P280347 (Exp 8/13); P280404, P280404A, P285635, P285858 (Exp 11/13); and P280149 (Exp 8/13).

  • Brand
    Baxter
  • Category
    Drug
FDA recall event · 6 products

All 6 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide & Puerto Rico
Recall numberProduct, codes & lotsQuantityNDC
D-624-20130.9% Sodium Chloride Injection, USP, in MINI-BAG Plus Container, a) 50 mL (NDC 0338-0553-11), b) 100 mL (NDC 0338-0553-18), Rx Only, Baxter, Deerfield, IL 60015; Lot #: a) Product code 2B0042: P285668, P285668A, P285668C, P285734, Exp 5/13; b) Product code 2B0043: P285395, Exp 5/13845,520 units0338-0553-11, 0338-0553-18
D-625-20135% Dextrose Injection, USP, in VIAFLEX Plastic Container Multi Pack, Rx Only, a) 50 mL (NDC 0338-0017-31), b) 100 mL (NDC 0338-0017-38), Baxter, Deerfield, IL 60015; Lot #: a) Product code 2B0088: P280115, P285239, Exp 7/13; b) Product code 2B0089: P280230, P280461, P285288, P285288A, P285783, Exp 8/13730,848 units0338-0017-10, 0338-0017-41, 0338-0017-11, 0338-0017-31, 0338-0017-48, 0338-0017-18, 0338-0017-38, 0338-0017-02, 0338-0017-03, 0338-0017-04, 0338-0023-02, 0338-0023-03, 0338-0023-04
D-626-2013Heparin Sodium and 0.9% Sodium Chloride Injection, a) Product code 2B0944, 2000 USP Units, Viaflex Plus Container, 1000mL, (NDC 0338-0433-04), b) Product code 2B0953: 1000 USP Units, Viaflex Plus Container, 500 mL (NDC 0338-0431-03), Baxter, Deerfield, IL 60015; Lot #: a) Product code 2B0944: N001164, Exp 7/13; b) Product code 2B0953: N001396, Exp 11/13N/A0338-0431-03, 0338-0433-04, 0338-0424-18, 0338-0428-12
D-627-2013Lidocaine Hydrochloride and 5% Dextrose Injection, USP, 2g VIAFLEX Plus Plastic Container, 500mL, Rx Only, Baxter, Deerfield, IL 60015; Lot #: Product code 2B0973: P279935, Exp 7/13N/A—
D-628-2013Sodium Chloride Injection, USP, a) Product code 2B1301- 50 mL in Viaflex Container Quad Pack (NDC 0338-0049-11); b) 2B1302- 100mL in Viaflex Quad Pack (NDC 0338-0049-18); c) 2B1306- 50 mL in Viaflex Single Pack (NDC 0338-0049-41; d) 2B1307- 100mL in Viaflex Single Pack (NDC 0338-0049-48); e) 2B1308- 50 ML in Viaflex Multi Pack (NDC 0338-0049-31); f) 2B1309- 100mL in Viaflex Multi Pack (NDC 0338-0049-38), Rx Only, Baxter, Deerfield, IL 60015; Lot #: a) Product code 2B1301: P279943, P280370, Exp 7/13; b) Product code 2B1302: P280248, P280248A, P280248B, P285346, P285791, Exp 8/13; c) Product code 2B1306: P285601, Exp 5/13; d) Product code 2B1307: P280347, Exp 8/13; e) Product code 2B1308: P280404, P280404A, P285635, P285858, Exp 11/13; e) Product code 2B1309: P280149, Exp 8/131,788,292 units0338-0049-01, 0338-0049-02, 0338-0049-03, 0338-0049-04, 0338-0049-10, 0338-0049-41, 0338-0049-11, 0338-0049-31, 0338-0049-48, 0338-0049-18, 0338-0049-38, 0338-0043-03, 0338-0043-04
D-629-2013Metronidazole Injection USP, RTU, 500 mg/100mL in Viaflex Plus Container, Baxter, Deerfield, IL 60015, NDC 0338-1055-48; Lot #: P280123, P280123A, Exp 2/14172,296 units0338-1055-48
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Affected Lots

    Immediately quarantine and do not administer any Sodium Chloride Injection, USP units matching the specific product codes, lot numbers, and expiration dates listed in the recall record.

  2. Contact Baxter for Details

    Reach out to Baxter Healthcare Corp. directly for further instructions on returning or disposing of the recalled units, as the specific remedy details are not provided in this record summary.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide & Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.1 years after the firm started it.

1. Firm started the recall: May 21, 201312. FDA classified it Class II: Jun 28, 201323. Published in FDA’s Enforcement Report: Jul 10, 201334. FDA terminated the recall: Jun 18, 2015420132015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What are the expiration dates for the recalled products?

Expiration dates range from May 2013 to November 2013, depending on the specific product code and lot number.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-628-2013 (May 21, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-628-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA